RxSight Inc
(NAS:RXST)
$
56.45
2.12 (3.9%)
Market Cap: 2.24 Bil
Enterprise Value: 2.02 Bil
PE Ratio: 0
PB Ratio: 8.13
GF Score: 58/100 - Q2 2024 Rxsight Inc Earnings Call TranscriptAug 05, 2024$40.78 (-2.37%)Earnings
- Q1 2024 Rxsight Inc Earnings Call TranscriptMay 06, 2024$62.84 (+1.88%)Earnings
- Q4 2023 Rxsight Inc Earnings Call TranscriptFeb 28, 2024$56.39 (-2.64%)Earnings
- Rxsight Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Rxsight Inc Earnings Call TranscriptNov 09, 2023$23.8 (-4.19%)Earnings
- Q2 2023 Rxsight Inc Earnings Call TranscriptAug 07, 2023$28.84 (-4.09%)Earnings
- Rxsight Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Rxsight Inc Earnings Call TranscriptMay 09, 2023$19.25 (-0.82%)Earnings
- Rxsight Inc at Needham Healthcare Conference (Virtual) TranscriptApr 19, 2023
- Rxsight Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q4 2022 Rxsight Inc Earnings Call TranscriptMar 06, 2023$15.69 (+12.96%)Earnings
- Rxsight Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Rxsight Inc Earnings Call TranscriptNov 07, 2022$12.62 (+7.86%)Earnings
- Q2 2022 Rxsight Inc Earnings Call TranscriptAug 08, 2022$15.65 (-0.32%)Earnings
- Q1 2022 Rxsight Inc Earnings Call TranscriptMay 05, 2022$10.61 (-10.54%)Earnings
Rxsight Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023 / 10:55PM GMT
Release Date Price:
$21.15
(+9.87%)
Craig William Bijou
BofA Securities, Research Division - Research Analyst
Craig Bijou, medical device analyst for BofA. And it's a pleasure to have RxSight here, and from the company, Ron Kurtz, CEO; and Shelley Thunen, CFO. So Ron, Shelley, thank you for coming.
Shelley B. Thunen
RxSight, Inc. - CFO & Assistant Secretary
Thank you very much for having us.
Craig William Bijou
BofA Securities, Research Division - Research Analyst
So it's a bit of an abbreviated fireside chat, so I kind of want to hit on the hot topics.
Questions & Answers
Craig William Bijou;
BofA Securities, Research Division - Research Analyst
ASCRS obviously happened last weekend. And from what we've heard, there was a lot of buzz around you guys. So would just love to hear your feedback from the conference, what the feedback from docs were? How does that compare to prior year conferences? And is there an acceleration in interest in you guys and in your technology?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)